APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nattokinase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nattokinase Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchNattokinase Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Nattokinase Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Nattokinase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nattokinase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nattokinase Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nattokinase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nattokinase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nattokinase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nattokinase market include Contek Life Science, Daiwa Pharmaceutical, Japan Bio Science Laboratory and Sungen Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nattokinase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nattokinase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nattokinase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nattokinase market size, projected growth trends, production technologies, key applications, and end-use industries.

Nattokinase Segment by Company

Contek Life Science

Daiwa Pharmaceutical

Japan Bio Science Laboratory

Sungen Bioscience

Nattokinase Segment by Type

Above 20001 Fu/g

10001-20000 Fu/g

0-10000 Fu/g

Nattokinase Segment by Application

Dietary Supplement

Others

Nattokinase Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nattokinase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nattokinase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nattokinase significant trends, drivers, influence factors in global and regions.

6. To analyze Nattokinase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nattokinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nattokinase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nattokinase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nattokinase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nattokinase industry.

Chapter 3: Detailed analysis of Nattokinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nattokinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nattokinase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nattokinase Industry Trends Table 2. Nattokinase Industry Drivers Table 3. Nattokinase Industry Opportunities and Challenges Table 4. Nattokinase Industry Restraints Table 5. Global Nattokinase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nattokinase Revenue Share by Company (2021-2026) Table 7. Global Nattokinase Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Nattokinase Sales Volume Share by Company (2021-2026) Table 9. Global Nattokinase Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Nattokinase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nattokinase Key Company Manufacturing Base & Headquarters Table 12. Global Nattokinase Company, Product Type & Application Table 13. Global Nattokinase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nattokinase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Above 20001 Fu/g Table 18. Significant Companies of 10001-20000 Fu/g Table 19. Significant Companies of 0-10000 Fu/g Table 20. Global Nattokinase Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Nattokinase Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Nattokinase Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Nattokinase Sales Volume Share by Type (2021-2026) Table 24. Global Nattokinase Sales Volume Share by Type (2027-2032) Table 25. Global Nattokinase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nattokinase Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nattokinase Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nattokinase Sales Value Share by Type (2021-2026) Table 29. Global Nattokinase Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Dietary Supplement Table 31. Significant Companies of Others Table 32. Global Nattokinase Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 33. Global Nattokinase Sales Volume by Application (2021-2026) & (Tons) Table 34. Global Nattokinase Sales Volume by Application (2027-2032) & (Tons) Table 35. Global Nattokinase Sales Volume Share by Application (2021-2026) Table 36. Global Nattokinase Sales Volume Share by Application (2027-2032) Table 37. Global Nattokinase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nattokinase Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Nattokinase Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Nattokinase Sales Value Share by Application (2021-2026) Table 41. Global Nattokinase Sales Value Share by Application (2027-2032) Table 42. Global Nattokinase Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 43. Global Nattokinase Sales by Region (2021-2026) & (Tons) Table 44. Global Nattokinase Sales Market Share by Region (2021-2026) Table 45. Global Nattokinase Sales by Region (2027-2032) & (Tons) Table 46. Global Nattokinase Sales Market Share by Region (2027-2032) Table 47. Global Nattokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nattokinase Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Nattokinase Sales Value Share by Region (2021-2026) Table 50. Global Nattokinase Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Nattokinase Sales Value Share by Region (2027-2032) Table 52. Global Nattokinase Market Average Price (US$/Ton) by Region (2021-2026) Table 53. Global Nattokinase Market Average Price (US$/Ton) by Region (2027-2032) Table 54. Global Nattokinase Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Global Nattokinase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Nattokinase Sales by Country (2021-2026) & (Tons) Table 57. Global Nattokinase Sales Market Share by Country (2021-2026) Table 58. Global Nattokinase Sales by Country (2027-2032) & (Tons) Table 59. Global Nattokinase Sales Market Share by Country (2027-2032) Table 60. Global Nattokinase Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Nattokinase Sales Value Market Share by Country (2021-2026) Table 62. Global Nattokinase Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Nattokinase Sales Value Market Share by Country (2027-2032) Table 64. Contek Life Science Company Information Table 65. Contek Life Science Business Overview Table 66. Contek Life Science Nattokinase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Contek Life Science Nattokinase Product Portfolio Table 68. Contek Life Science Recent Development Table 69. Daiwa Pharmaceutical Company Information Table 70. Daiwa Pharmaceutical Business Overview Table 71. Daiwa Pharmaceutical Nattokinase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. Daiwa Pharmaceutical Nattokinase Product Portfolio Table 73. Daiwa Pharmaceutical Recent Development Table 74. Japan Bio Science Laboratory Company Information Table 75. Japan Bio Science Laboratory Business Overview Table 76. Japan Bio Science Laboratory Nattokinase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Japan Bio Science Laboratory Nattokinase Product Portfolio Table 78. Japan Bio Science Laboratory Recent Development Table 79. Sungen Bioscience Company Information Table 80. Sungen Bioscience Business Overview Table 81. Sungen Bioscience Nattokinase Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Sungen Bioscience Nattokinase Product Portfolio Table 83. Sungen Bioscience Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Nattokinase Distributors List Table 87. Nattokinase Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Nattokinase Product Image Figure 2. Global Nattokinase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nattokinase Sales (2021-2032) & (Tons) Figure 5. Global Nattokinase Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Nattokinase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Above 20001 Fu/g Image Figure 10. 10001-20000 Fu/g Image Figure 11. 0-10000 Fu/g Image Figure 12. Global Nattokinase Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Nattokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nattokinase Sales Volume Share by Type (2021-2032) Figure 15. Global Nattokinase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nattokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nattokinase Sales Value Share by Type (2021-2032) Figure 18. Dietary Supplement Image Figure 19. Others Image Figure 20. Global Nattokinase Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 21. Global Nattokinase Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Nattokinase Sales Volume Share by Application (2021-2032) Figure 23. Global Nattokinase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nattokinase Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nattokinase Sales Value Share by Application (2021-2032) Figure 26. Global Nattokinase Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 27. Global Nattokinase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nattokinase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nattokinase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 31. North America Nattokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Nattokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Nattokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 37. South America Nattokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Nattokinase Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Nattokinase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Nattokinase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Nattokinase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Nattokinase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Nattokinase Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Nattokinase Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Above 20001 Fu/g
  • 10001-20000 Fu/g
  • 0-10000 Fu/g
Applications
  • Dietary Supplement
  • Others
Companies covered
  • Contek Life Science
  • Daiwa Pharmaceutical
  • Japan Bio Science Laboratory
  • Sungen Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nattokinase Sales Value (2021-2032)
  4. 1.2.2 Global Nattokinase Sales Volume (2021-2032)
  5. 1.2.3 Global Nattokinase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nattokinase Market Dynamics
  1. 2.1 Nattokinase Industry Trends
  2. 2.2 Nattokinase Industry Drivers
  3. 2.3 Nattokinase Industry Opportunities and Challenges
  4. 2.4 Nattokinase Industry Restraints
3 Nattokinase Market by Company
  1. 3.1 Global Nattokinase Company Revenue Ranking in 2025
  2. 3.2 Global Nattokinase Revenue by Company (2021-2026)
  3. 3.3 Global Nattokinase Sales Volume by Company (2021-2026)
  4. 3.4 Global Nattokinase Average Price by Company (2021-2026)
  5. 3.5 Global Nattokinase Company Ranking (2024-2026)
  6. 3.6 Global Nattokinase Company Manufacturing Base and Headquarters
  7. 3.7 Global Nattokinase Company Product Type and Application
  8. 3.8 Global Nattokinase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nattokinase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nattokinase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nattokinase Market by Type
  1. 4.1 Nattokinase Type Introduction
  2. 4.1.1 Above 20001 Fu/g
  3. 4.1.2 10001-20000 Fu/g
  4. 4.1.3 0-10000 Fu/g
  5. 4.2 Global Nattokinase Sales Volume by Type
  6. 4.2.1 Global Nattokinase Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nattokinase Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nattokinase Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nattokinase Sales Value by Type
  10. 4.3.1 Global Nattokinase Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nattokinase Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nattokinase Sales Value Share by Type (2021-2032)
5 Nattokinase Market by Application
  1. 5.1 Nattokinase Application Introduction
  2. 5.1.1 Dietary Supplement
  3. 5.1.2 Others
  4. 5.2 Global Nattokinase Sales Volume by Application
  5. 5.2.1 Global Nattokinase Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nattokinase Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Nattokinase Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Nattokinase Sales Value by Application
  9. 5.3.1 Global Nattokinase Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nattokinase Sales Value by Application (2021-2032)
  11. 5.3.3 Global Nattokinase Sales Value Share by Application (2021-2032)
6 Nattokinase Regional Sales and Value Analysis
  1. 6.1 Global Nattokinase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nattokinase Sales by Region (2021-2032)
  3. 6.2.1 Global Nattokinase Sales by Region: 2021-2026
  4. 6.2.2 Global Nattokinase Sales by Region (2027-2032)
  5. 6.3 Global Nattokinase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nattokinase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nattokinase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nattokinase Sales Value by Region (2027-2032)
  9. 6.5 Global Nattokinase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nattokinase Sales Value (2021-2032)
  12. 6.6.2 North America Nattokinase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nattokinase Sales Value (2021-2032)
  15. 6.7.2 Europe Nattokinase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nattokinase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nattokinase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nattokinase Sales Value (2021-2032)
  21. 6.9.2 South America Nattokinase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nattokinase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nattokinase Sales Value Share by Country, 2025 VS 2032
7 Nattokinase Country-level Sales and Value Analysis
  1. 7.1 Global Nattokinase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nattokinase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nattokinase Sales by Country (2021-2032)
  4. 7.3.1 Global Nattokinase Sales by Country (2021-2026)
  5. 7.3.2 Global Nattokinase Sales by Country (2027-2032)
  6. 7.4 Global Nattokinase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nattokinase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nattokinase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nattokinase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nattokinase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nattokinase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nattokinase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nattokinase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nattokinase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nattokinase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nattokinase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nattokinase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nattokinase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nattokinase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nattokinase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nattokinase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nattokinase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nattokinase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nattokinase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nattokinase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nattokinase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nattokinase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nattokinase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nattokinase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nattokinase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nattokinase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nattokinase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nattokinase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nattokinase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nattokinase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nattokinase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nattokinase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nattokinase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nattokinase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nattokinase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nattokinase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nattokinase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nattokinase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nattokinase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nattokinase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nattokinase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nattokinase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nattokinase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nattokinase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nattokinase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nattokinase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nattokinase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nattokinase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nattokinase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nattokinase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nattokinase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nattokinase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nattokinase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nattokinase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nattokinase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nattokinase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nattokinase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nattokinase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nattokinase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nattokinase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nattokinase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nattokinase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nattokinase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nattokinase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nattokinase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nattokinase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nattokinase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nattokinase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nattokinase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nattokinase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nattokinase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nattokinase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nattokinase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nattokinase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nattokinase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nattokinase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nattokinase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nattokinase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nattokinase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nattokinase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nattokinase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nattokinase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nattokinase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nattokinase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nattokinase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nattokinase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nattokinase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Contek Life Science
  2. 8.1.1 Contek Life Science Company Information
  3. 8.1.2 Contek Life Science Business Overview
  4. 8.1.3 Contek Life Science Nattokinase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Contek Life Science Nattokinase Product Portfolio
  6. 8.1.5 Contek Life Science Recent Developments
  7. 8.2 Daiwa Pharmaceutical
  8. 8.2.1 Daiwa Pharmaceutical Company Information
  9. 8.2.2 Daiwa Pharmaceutical Business Overview
  10. 8.2.3 Daiwa Pharmaceutical Nattokinase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Daiwa Pharmaceutical Nattokinase Product Portfolio
  12. 8.2.5 Daiwa Pharmaceutical Recent Developments
  13. 8.3 Japan Bio Science Laboratory
  14. 8.3.1 Japan Bio Science Laboratory Company Information
  15. 8.3.2 Japan Bio Science Laboratory Business Overview
  16. 8.3.3 Japan Bio Science Laboratory Nattokinase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Japan Bio Science Laboratory Nattokinase Product Portfolio
  18. 8.3.5 Japan Bio Science Laboratory Recent Developments
  19. 8.4 Sungen Bioscience
  20. 8.4.1 Sungen Bioscience Company Information
  21. 8.4.2 Sungen Bioscience Business Overview
  22. 8.4.3 Sungen Bioscience Nattokinase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sungen Bioscience Nattokinase Product Portfolio
  24. 8.4.5 Sungen Bioscience Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nattokinase Value Chain Analysis
  2. 9.1.1 Nattokinase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nattokinase Sales Mode & Process
  6. 9.2 Nattokinase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nattokinase Distributors
  9. 9.2.3 Nattokinase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst